Europe Cancer Photodynamic Therapy Market
시장 규모 (USD 10억)
연평균 성장률 :
% 
USD
872.14 Million
USD
1,353.25 Million
2024
2032
 예측 기간 |
2025 –2032 |
 시장 규모(기준 연도) |
USD 872.14 Million |
 시장 규모(예측 연도) |
USD 1,353.25 Million |
 연평균 성장률 |
% |
| 주요 시장 플레이어 |
|
유럽 암 광역학 치료 시장 세분화, 제품 유형별(광감작제, 광역학 치료 장치), 암 적응증별(피부 및 피부 종양학, 두경부, 식도, 폐, 방광, 자궁경부, 전립선), 치료 방식별(단독 치료, 보조 치료, 완화 치료, 기타), 시술 기법별(외부 빔, 체강 내(내시경) 전달, 간질(내부) 전달, 기타), 질병 단계별(초기 암, 후기 암), 환자 인구 통계별(노인, 성인, 소아), 최종 사용자별(병원, 피부과 및 피부암 클리닉, 외래 수술 센터(ASCS), 학술 및 연구 기관, 기타), 유통 채널별(직접 입찰, 제3자 유통업체, 온라인, 기타) - 산업 동향 및 2032년까지의 예측
유럽 암 광역학 치료 시장 규모
- 유럽 암 광역학 치료 시장은 2024년에 8억 7,214만 달러 규모로 평가되었으며 예측 기간 동안 5.8%의 CAGR 로 2032년까지 1,353.25만 달러 에 도달할 것으로 예상됩니다.
- 이 시장은 주로 암 유병률 증가, 의료비 지출 증가, 그리고 첨단 치료 옵션에 대한 인식 제고에 의해 주도되고 있습니다. 의료 인프라의 급속한 개선, 전문 암 치료 센터의 확장 등이 이러한 추세를 뒷받침합니다.
- 이러한 성장은 조기 진단 및 혁신적 치료법을 장려하는 정부 이니셔티브, 대규모 환자 풀, 광역학 치료 기술에 대한 국제 및 국내 기업의 투자 증가와 같은 요인에 의해 촉진됩니다.
유럽 암 광역학 치료 시장 분석
- 암 광역학 치료(PDT) 시장은 암 유병률 증가, 비침습적 치료에 대한 인식 증가, 광감각제 약물 및 레이저 기술의 발전에 힘입어 꾸준한 성장을 경험하고 있습니다.
- 신흥 시장에서는 정부 정책, 의료비 지출 증가, 그리고 노령 인구 증가에 힘입어 광역학 치료(PDT) 도입이 빠르게 증가하고 있습니다. 그러나 높은 치료비와 제한된 보험 급여는 여전히 주요 제약으로 남아 있는 반면, 병용 요법과 표적 광감작제 분야의 지속적인 혁신은 상당한 성장 기회를 제공합니다.
- 독일은 첨단 의료 인프라, 혁신적 치료법의 높은 채택, 강력한 R&D 투자, 유리한 보상 정책 및 최소 침습 치료법에 대한 인식에 힘입어 2025년에 19.26%의 가장 큰 수익 점유율로 유럽 암 광역학 치료 시장을 지배할 것으로 예상됩니다.
- 독일은 예측 기간 동안 유럽 암 광역학 치료 시장에서 가장 빠르게 성장하는 지역으로, 연평균 성장률 8.9%를 기록할 것으로 예상됩니다. 이는 암 유병률 증가, 의료 인프라 확충, 첨단 치료법에 대한 인식 제고, 그리고 조기 진단을 장려하는 정부 정책에 힘입은 것입니다. 또한, 혁신 기술 도입 증가와 가처분 소득 증가는 이 지역의 광역학 치료 수요를 견인하고 있습니다.
- 광감각제 약물 부문은 2025년에 75.15%의 시장 점유율로 유럽 암 광역학 치료 시장을 지배할 것으로 예상됩니다. 이는 치료에 있어서 중심적인 역할, 암세포를 표적으로 삼는 높은 특이성, 새로운 약물 승인 증가, 복합 치료에서의 채택 증가, 향상된 효능과 감소된 부작용을 촉진하는 지속적인 R&D에 힘입은 것입니다.
보고서 범위 및 유럽 암 광역학 치료 시장 세분화
|
속성 |
실크 키 시장 통찰력 |
|
다루는 세그먼트 |
|
|
포함 국가 |
유럽
|
|
주요 시장 참여자 |
|
|
시장 기회 |
|
|
부가가치 데이터 정보 세트 |
Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체 등 시장 시나리오에 대한 통찰력 외에도 수입 수출 분석, 생산 능력 개요, 생산 소비 분석, 가격 추세 분석, 기후 변화 시나리오, 공급망 분석, 가치 사슬 분석, 원자재/소모품 개요, 공급업체 선택 기준, PESTLE 분석, Porter 분석 및 규제 프레임워크가 포함됩니다. |
유럽 암 광역학 치료 시장 동향
“다른 암 치료법과의 통합”
- 광역학 치료(PDT)는 면역 반응을 자극하면서 국소적인 종양 세포 사멸을 유도하는 능력이 있어 다중 모드 암 치료에 매력적인 파트너로 자리매김하고 있습니다.
- 증가하는 증거에 따르면 PDT는 종양 항원 방출을 증가시키고 종양 미세 환경을 조절하며 면역 세포의 침투 또는 활성화를 향상시킬 수 있습니다. 이러한 메커니즘은 면역 체크포인트 억제제, 치료용 암 백신, 화학 요법 또는 방사선 요법과 함께 시너지 효과를 낼 수 있습니다.
- PDT를 전신 치료와 결합하면 국소적 조절을 지속 가능한 전신적 반응으로 전환하고 독성 물질의 복용량을 줄이고 적응증(예: 절제 불가능하거나 전이성 질환)을 확대할 수 있습니다.
- 임상 및 전환 연구가 증가함에 따라 다른 방식과의 통합은 PDT의 임상적 관련성과 상업적 활용을 확대하는 고가치 경로를 나타냅니다.
유럽 암 광역학 치료 시장 동향
운전사
“암 유병률 증가”
- 전 세계적으로 암 유병률이 증가하고 있는 것은 광역학 치료(PDT)와 같은 치료법에 대한 수요를 촉진하는 가장 중요한 요인 중 하나입니다.
- 인구가 증가하고 고령화되고 진단 도구가 개선됨에 따라 매년 더 많은 암 사례가 발견되고 있습니다.
- 저소득 및 중소득 국가에서는 담배 사용, 비만, 앉아서 보내는 생활 방식, 대기 오염, 감염과 같은 위험 요소의 비율이 더 높기 때문에 발병률이 증가하고 있습니다.
- 효과적이고 덜 침습적이며 비용 효율적인 국소 치료 방식을 필요로 하는 환자가 늘어나면서 PDT가 더욱 매력적으로 다가오고 있습니다.
- 이러한 암 부담의 증가는 건강 시스템에 스트레스를 주어 결과를 개선하고 부작용을 줄이며 보다 광범위하게 배포할 수 있는 치료법에 대한 긴급한 압력을 발생시킵니다.
제지/도전
"제한된 빛 투과 깊이"
- 광역학 치료의 폭넓은 채택과 효과를 방해하는 중요한 제한은 활성화 빛이 인체 조직으로 침투하는 데 제한이 있다는 것입니다.
- 광감각제는 특정 파장의 빛에 의해 활성화되어야 하기 때문에 조직에 의한 빛의 흡수 및 산란으로 인해 조명이 도달할 수 있는 깊이가 줄어듭니다.
- 가시광선 PS는 종종 표면적이거나 쉽게 접근 가능한 종양에만 효과가 있습니다. 더 깊거나 더 큰 종양은 여전히 어렵습니다.
- 이러한 제한으로 인해 종양이 완전히 파괴되지 않고 침습적 빛 전달(예: 광섬유 프로브, 내시경)이 필요해지고 시술이 복잡해지며 결과가 좋지 않거나 재발할 수 있습니다.
- 획기적인 발전이 이를 극복할 때까지 PDT는 비침습적이고 효과적으로 치료할 수 있는 암의 범위가 제한됩니다.
유럽 암 광역학 치료 시장 범위
시장은 제품 유형, 암 적응증, 치료 방식, 시술 기술, 질병 단계, 환자 인구 통계, 최종 사용자 및 유통 채널을 기준으로 세분화됩니다.
- 제품 유형별
유럽 암 광역학 치료 시장은 제품 유형에 따라 광감작제와 광역학 치료 기기로 구분됩니다. 2025년에는 광감작제가 치료 효능에 중요한 역할을 하고, 다양한 암 유형에 광범위하게 적용 가능하며, 다양한 제형(정맥, 국소, 경구, 방광, 복강)으로 사용 가능하기 때문에 75.15%의 시장 점유율을 차지할 것으로 예상됩니다. 이러한 시장 지배력을 뒷받침하는 주요 요인으로는 암 유병률 증가, 최소 침습 치료법 도입 증가, 지속적인 약물 혁신, 그리고 규제 기관의 승인 등이 있으며, 이러한 요소들이 합쳐져 광감작제가 PDT 기기보다 주요 매출원으로서의 위치를 차지하고 있습니다.
광감작제는 표적 및 최소 침습 암 치료법의 도입 증가로 인해 유럽 암 광역학 치료 시장에서 연평균 성장률 5.9%로 가장 빠르게 성장하는 분야입니다. PDT의 효과에 대한 인지도 향상, 기존 치료법 대비 부작용 감소, 그리고 향상된 종양 선택성과 더 깊은 조직 침투를 가진 차세대 광감작제 개발이 수요를 견인하고 있습니다. 또한, 새로운 광감작제에 대한 임상 연구 및 승인 확대는 시장 확대를 촉진하고 있습니다.
- 암 징후에 따라
유럽 암 광역학 치료 시장은 암 적응증을 기준으로 피부 및 피부 종양, 두경부, 식도, 폐, 방광, 자궁경부, 전립선으로 세분화됩니다. 피부 및 피부 종양 부문은 피부암의 높은 유병률, 조기 발견에 대한 광범위한 인식, 그리고 탁월한 미용적 결과를 달성하는 PDT의 효과로 인해 2025년에는 52.21%의 시장 점유율을 차지하며 시장을 장악할 것으로 예상됩니다. 이 부문은 광감각제 약물과 PDT 기기의 광범위한 도입, 특히 환자 수가 가장 많은 노인 및 성인 환자를 위한 혜택을 누리고 있습니다. 또한, 광선각화증, 기저세포암, 편평세포암에 대한 최소 침습 표적 치료법에 대한 수요 증가와 주요 지역의 유리한 보험급여 정책은 다른 암 적응증에 대한 시장 선도력을 더욱 강화하고 있습니다.
피부 및 피부 종양학 분야는 피부암 유병률 증가, 조기 진단에 대한 인식 제고, 그리고 부작용이 적은 최소 침습적 치료법에 대한 선호로 인해 유럽 암 광역학 치료 시장에서 연평균 성장률 6.3%로 가장 빠르게 성장하고 있습니다. 광역학 치료는 표적 치료 효과, 빠른 회복, 그리고 향상된 미용적 효과를 제공하여 피부 종양학 분야에 매우 유리한 위치를 차지하고 있습니다. 또한, 광감작제와 광 전달 시스템의 기술 발전이 이 분야의 도입을 촉진하고 있습니다.
- 치료 방식에 따라
유럽 암 광역학 치료 시장은 치료 방식에 따라 단독 치료, 보조 치료, 완화 치료, 기타로 구분됩니다. 2025년에는 단독 치료 부문이 피부암, 식도암, 폐암 등 국소암의 1차 치료로서 효과적이라는 점에서 시장 점유율 41.20%를 차지할 것으로 예상됩니다. 이러한 우위를 점하는 주요 요인으로는 높은 효능, 최소 침습성, 우수한 미용적 효과, 그리고 표적 치료에 대한 임상적 선호도 증가가 있습니다. 지역적으로는 북미와 유럽이 선진 의료 인프라, 확립된 보험급여 체계, 그리고 높은 환자 인지도로 단독 PDT 도입을 주도하고 있으며, 아시아 태평양 신흥 시장은 암 유병률 증가, 병원 네트워크 확장, 그리고 현대 종양학 치료법 접근성 향상에 힘입어 도입률이 증가하고 있습니다. 이러한 지역적 역동성과 PDT의 이점에 대한 교육 및 인지도 향상은 전 세계적으로 단독 치료의 우위를 더욱 강화하고 있습니다.
단독 치료는 유럽 암 광역학 치료 시장에서 연평균 성장률 6.2%로 가장 빠르게 성장하는 분야입니다. 이는 단순성, 비용 효율성, 그리고 병용 요법 대비 부작용 감소 덕분입니다. 단독 치료는 추가 약물이나 중재 없이도 표적 종양 치료를 가능하게 하여 환자의 순응도를 향상시킵니다. 외래 환자 진료에서의 도입률 증가, 최소 침습 치료에 대한 인식 제고, 그리고 광감작제 및 광 전달 시스템의 발전은 이 분야의 빠른 성장을 더욱 촉진하고 있습니다.
- 절차 기술에 따라
유럽 암 광역학 치료 시장은 시술 기법을 기준으로 체외 빔, 체강내(내시경) 투여, 간질(체내) 투여, 기타로 구분됩니다. 2025년에는 체외 빔 분야가 비침습적 특성, 사용 편의성, 그리고 표재성 종양에 대한 효과성을 바탕으로 68.97%의 시장 점유율을 차지할 것으로 예상됩니다. 북미와 유럽에서의 높은 도입률, 선진 의료 인프라 및 보험급여 정책, 그리고 암 유병률 및 인식 증가에 따른 아시아 태평양 지역의 수요 증가가 체외 빔 분야가 시장을 선도하는 데 기여하고 있습니다.
체강내(내시경) 투여 부문은 유럽 암 광역학 치료 시장에서 6.3%의 CAGR로 가장 빠르게 성장하고 있습니다. 이 부문은 중공 기관 종양에 최소 침습적이고 표적화된 빛과 광감각제를 투여하고, 전신 노출과 부작용을 줄이며, 반복 가능한 치료를 가능하게 하고, 식도암, 기관지암, 방광암에서 종양 접근성을 개선하고 회복 시간을 단축합니다.
- 질병 단계별
유럽 암 광역학 치료 시장은 질병 단계에 따라 초기 암과 후기 암으로 구분됩니다. 2025년에는 초기 암 분야가 81.51%의 점유율로 시장을 장악할 것으로 예상됩니다. 이는 PDT가 국소 종양을 효과적으로 타겟팅하고, 건강한 조직 손상을 최소화하며, 더 나은 미용적 결과를 제공하기 때문입니다. 이 분야는 높은 환자 인지도, 최소 침습 치료에 대한 선호도, 그리고 북미와 유럽에서의 광범위한 도입을 통해 이점을 누리고 있으며, 아시아 태평양 지역의 암 진단율 증가와 종양학 인프라 확장은 시장 선도력을 더욱 강화합니다.
초기 암은 최소 침습적 치료법 도입 증가, 조기 진단에 대한 인식 제고, 그리고 PDT(광역학 치료)를 통한 환자 치료 결과 개선으로 인해 유럽 암 광역학 치료 시장에서 연평균 성장률 5.8%로 가장 빠르게 성장하는 분야입니다. 초기 암은 표적 치료에 더 잘 반응하여 효능이 더 높고 부작용은 적습니다. 또한, 정부의 적극적인 지원 정책과 광감작제 및 광선 전달 시스템의 발전은 이 분야의 시장 침투를 가속화하고 있습니다.
- 환자 인구 통계별
환자 인구 통계를 기준으로 유럽 암 광역학 치료 시장은 노인, 성인, 소아로 구분됩니다. 2025년에는 노인 암 유병률 증가, 피부암 및 피부암에 대한 취약성 증가, 그리고 최소 침습적 표적 치료에 대한 선호로 인해 노인 부문이 67.12%의 시장 점유율을 차지하며 시장을 주도할 것으로 예상됩니다. 북미와 유럽에서는 선진 의료 인프라와 인지도, 그리고 고령 인구 증가에 힘입어 광역학 치료가 활발하게 도입되고 있습니다.
노인층은 유럽 암 광역학 치료 시장에서 연평균 성장률 6.0%로 가장 빠르게 성장하고 있는데, 이는 노인층의 높은 암 유병률 때문입니다. 노화는 면역 체계를 약화시키고 다양한 암에 대한 취약성을 증가시켜 PDT와 같은 효과적이고 최소 침습적인 치료에 대한 수요를 증가시킵니다. 또한, PDT는 부작용이 적고 회복이 빠르기 때문에 공격적인 치료를 견디기 어려운 노인 환자에게 적합하며, 이는 이 연령대의 시장 성장을 촉진합니다.
- 최종 사용자별
유럽 암 광역학 치료 시장은 최종 사용자 기준으로 병원, 피부과 및 피부암 클리닉, 외래 수술 센터(ASCS), 학술 및 연구 기관, 기타로 구분됩니다. 2025년에는 병원 부문이 포괄적인 인프라, 전문 종양학과의 가용성, 그리고 통합 PDT 치료 제공 능력 덕분에 41.33%의 시장 점유율을 기록하며 시장을 주도할 것으로 예상됩니다. 북미와 유럽의 공립 및 사립 병원, 특히 1등급 및 2등급 병원은 선진 의료 시스템과 보험급여 지원 덕분에 도입을 주도하고 있습니다. 아시아 태평양 지역의 병원 네트워크 확장과 종양학 서비스 확대는 전 세계적으로 암 PDT의 주요 최종 사용자로서 병원의 우위를 더욱 강화하고 있습니다.
병원은 첨단 암 치료법 도입 증가, 환자 유입 증가, 그리고 전문 종양학과의 확보로 인해 유럽 암 광역학 치료 시장에서 연평균 성장률 6.5%로 가장 빠르게 성장하는 분야입니다. 병원은 진단, 치료, 치료 후 관리 등 포괄적인 PDT 서비스를 제공하기 때문에 단독 진료소보다 선호됩니다. 또한, 인지도 향상, 정부 정책, 그리고 보험 적용 범위 확대는 병원 기반 PDT 도입을 더욱 촉진하고 있습니다.
- 유통 채널별
유럽 암 광역학 치료 시장은 유통 채널을 기준으로 직접 입찰, 제3자 유통업체, 온라인, 그리고 기타로 구분됩니다. 2025년에는 직접 입찰 부문이 50.79%의 시장 점유율을 차지할 것으로 예상됩니다. 병원, 정부 의료 프로그램, 그리고 대형 종양학 센터의 대량 조달을 통해 비용 효율성과 안정적인 광감작제 및 PDT 기기 공급을 확보할 수 있기 때문입니다. 북미와 유럽에서는 체계적인 병원 조달 시스템과 공공 보건 입찰, 그리고 증가하는 기관 수요 덕분에 직접 입찰이 활발하게 도입되고 있습니다.
직접 입찰 부문은 정부 및 병원의 직접 계약을 통한 첨단 PDT 기기 조달 증가로 인해 유럽 암 광역학 치료 시장에서 연평균 성장률 6.0%로 가장 빠르게 성장하고 있습니다. 이러한 접근 방식은 대규모 암 치료 프로그램에 대한 비용 효율성, 신속한 조달, 그리고 안정적인 공급을 보장합니다. 또한, 공공 의료비 지출 증가, 암 치료에 대한 정부 정책, 그리고 중앙 집중식 구매 선호로 인해 유통업체나 온라인 채널보다 직접 입찰이 더욱 활발하게 도입되고 있습니다.
유럽 암 광역학 치료 시장 지역 분석
- 독일은 첨단 의료 인프라, 혁신적 치료법의 높은 채택, 강력한 R&D 투자, 유리한 보상 정책 및 최소 침습 치료법에 대한 인식에 힘입어 2025년에 19.26%의 가장 큰 수익 점유율로 유럽 암 광역학 치료 시장을 지배할 것으로 예상됩니다.
- 독일은 예측 기간 동안 유럽 암 광역학 치료 시장에서 가장 빠르게 성장하는 지역으로, 연평균 성장률 8.9%를 기록할 것으로 예상됩니다. 이는 암 유병률 증가, 의료 인프라 확충, 첨단 치료법에 대한 인식 제고, 그리고 조기 진단을 장려하는 정부 정책에 힘입은 것입니다. 또한, 혁신 기술 도입 증가와 가처분 소득 증가는 이 지역의 광역학 치료 수요를 견인하고 있습니다.
- 또한 선도적인 시장 참여자와 지원 규제 프레임워크의 존재로 인해 해당 지역의 시장 성장과 채택률이 가속화됩니다.
영국 유럽 암 광역학 치료 시장 통찰력
영국 유럽 암 광역학 치료 시장은 탄탄한 의료 인프라, 선진 연구 역량, 그리고 탄탄한 종양학 센터를 기반으로 유럽 의료용 플라스틱 산업에서 중요한 역할을 담당하고 있습니다. 혁신적인 치료법의 높은 도입률, 암 치료에 대한 정부의 강력한 지원, 그리고 활발한 임상 시험이 시장 성장을 견인하고 있습니다. 또한, 영국 제약 회사와 연구 기관 간의 협력을 통해 광역학 치료(PDT)의 개발 및 상용화가 가속화되어 유럽 시장의 핵심적인 역할을 담당하고 있습니다.
독일 유럽 암 광역학 치료 시장 통찰력
독일 유럽 암 광역학 치료 시장은 선진 의료 인프라, 혁신적인 암 치료법의 높은 도입률, 그리고 정부의 강력한 종양학 연구 지원에 힘입어 꾸준히 성장할 것으로 예상됩니다. 최소 침습 치료법에 대한 인식 제고, 피부암 및 폐암 등 암 발병률 증가, 그리고 새로운 치료법에 대한 보험급여 정책은 도입을 더욱 촉진하고 있습니다. 또한, 주요 PDT 기기 제조업체의 입지와 연구 협력은 시장 침투와 지속적인 성장을 가속화하고 있습니다.
시장에서 활동하는 주요 시장 리더는 다음과 같습니다.
- Novartis Pharma AG(스위스)
- Galderma SA(스위스)
- Bausch Health Companies Inc.(캐나다)
- Photocure ASA(노르웨이)
- ADVANZ PHARMA Corp.(영국)
- Sun Pharmaceutical Industries Ltd.(인도)
- Biofrontera AG(독일)
- LUMIBIRD SA(프랑스)
- 루지틴 SA(포르투갈)
- 루메다 주식회사(스웨덴)
- ImPact Biotech(이스라엘)
- biolitec Holding GmbH & Co KG(독일)
- Modulight Corporation(핀란드)
- THERALASE TECHNOLOGIES INC. (캐나다)
유럽 암 광역학 치료 시장의 최신 동향
- 2023년 2월, 갈더마와 저먼 메디컬 엔지니어링(GME)의 협력은 피부과 및 광역학 치료(PDT) 시장의 전략적 발전을 의미합니다. 전암성 및 비흑색종 피부암 치료를 위한 선도적인 광감작제인 갈더마의 메트빅스(Metvix)와 GME의 멀티라이트(MultiLite) 기기를 결합함으로써, 이 파트너십은 갈더마의 통합 치료 솔루션을 강화하고 기존의 적색광 PDT(C-PDT)와 환자 친화적인 인공 일광 PDT(ADL-PDT)를 모두 제공할 수 있는 역량을 확대합니다.
- 2025년에 맥케슨은 코어 벤처스(커뮤니티 종양학 활성화 기업 벤처스)를 인수하여 약 24억 9천만 달러에 지배 지분의 약 70%를 인수하여 플로리다 암 전문가 및 연구소를 통해 지역 사회 기반 종양학 치료를 강화했습니다.
- 2025년에 Biofrontera AG는 Ameluz와 RhodoLED와 관련된 모든 미국 자산을 Biofrontera Inc.로 이전하여 10%의 지분과 미국 Ameluz 판매에 대한 12~15%의 로열티를 받았습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE CANCER PHOTODYNAMIC THERAPY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.8 DBMR MARKET POSITION GRID
2.9 MARKET END USER COVERAGE GRID
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 PRODUCTION CONSUMPTION ANALYSIS
4.3.1 INTRODUCTION
4.3.2 PRODUCTION SIDE ANALYSIS
4.3.2.1 PHOTOSENSITIZER MANUFACTURING
4.3.2.2 DEVICE MANUFACTURING
4.3.2.3 RESEARCH AND INNOVATION
4.3.3 CONSUMPTION SIDE ANALYSIS
4.3.3.1 CLINICAL APPLICATION
4.3.3.2 TREATMENT VOLUMES AND TRENDS
4.3.3.3 DOSAGE AND PROTOCOLS
4.3.4 PRODUCTION–CONSUMPTION DYNAMICS
4.3.4.1 SUPPLY CONSTRAINTS
4.3.4.2 REGIONAL OVERVIEW
4.3.4.3 FUTURE OUTLOOK
4.3.5 CONCLUSION
4.4 COST ANALYSIS BREAKDOWN
4.4.1 INTRODUCTION
4.4.2 DIRECT MEDICAL COSTS
4.4.2.1 COST OF PHOTOSENSITIZERS
4.4.2.2 LIGHT DELIVERY SYSTEMS
4.4.2.3 HEALTHCARE FACILITY CHARGES
4.4.3 INDIRECT COSTS
4.4.3.1 PATIENT-RELATED EXPENSES
4.4.3.2 POST-TREATMENT MONITORING
4.4.4 COMPARATIVE COST-EFFECTIVENESS
4.4.5 REIMBURSEMENT AND INSURANCE IMPACT
4.4.6 REGIONAL COST VARIATIONS
4.4.7 FUTURE COST TRENDS AND REDUCTION STRATEGIES
4.4.7.1 TECHNOLOGICAL ADVANCEMENTS
4.4.7.2 HEALTHCARE EFFICIENCY INITIATIVES
4.4.8 CONCLUSION
4.5 TECHNOLOGICAL ADVANCEMENTS
4.5.1 INTRODUCTION
4.5.2 NEXT-GENERATION PHOTOSENSITIZERS
4.5.3 ADVANCEMENTS IN LIGHT DELIVERY SYSTEMS
4.5.4 NANOTECHNOLOGY-ENABLED DELIVERY
4.5.5 COMBINATION THERAPIES AND IMMUNOMODULATION
4.5.6 DIGITAL INTEGRATION AND TREATMENT PLANNING
4.5.7 RECENT TRENDS AND OUTLOOK
4.5.8 CONCLUSION
4.6 VALUE CHAIN ANALYSIS
4.6.1 INTRODUCTION
4.6.2 RESEARCH & DEVELOPMENT
4.6.2.1 DISCOVERY OF PHOTOSENSITIZERS
4.6.2.2 DEVELOPMENT OF LIGHT DELIVERY SYSTEMS
4.6.2.3 CLINICAL TRIALS AND REGULATORY APPROVALS
4.6.3 MANUFACTURING
4.6.3.1 PRODUCTION OF PHOTOSENSITIZERS
4.6.3.2 FABRICATION OF LIGHT DELIVERY DEVICES
4.6.4 DISTRIBUTION & LOGISTICS
4.6.4.1 SUPPLY CHAIN MANAGEMENT
4.6.4.2 INTERNATIONAL TRADE AND MARKET ACCESS
4.6.5 CLINICAL APPLICATION
4.6.5.1 INTEGRATION INTO TREATMENT PROTOCOLS
4.6.5.2 TRAINING AND EDUCATION
4.6.6 POST-TREATMENT MONITORING & SUPPORT
4.6.6.1 FOLLOW-UP CARE
4.6.6.2 PATIENT SUPPORT SERVICES
4.6.7 TECHNOLOGICAL ADVANCEMENTS INFLUENCING THE PDT VALUE CHAIN
4.6.7.1 NANOTECHNOLOGY IN PDT
4.6.7.2 ARTIFICIAL INTELLIGENCE AND IMAGING
4.6.7.3 PERSONALIZED MEDICINE
4.6.8 CONCLUSION
4.7 VENDOR SELECTION CRITERIA
4.7.1 INTRODUCTION
4.7.2 CORE SELECTION CRITERIA
4.7.2.1 REGULATORY COMPLIANCE
4.7.2.2 CLINICAL EVIDENCE AND RESEARCH SUPPORT
4.7.2.3 TECHNICAL PERFORMANCE AND DEVICE COMPATIBILITY
4.7.2.4 QUALITY MANAGEMENT AND MANUFACTURING STANDARDS
4.7.2.5 SERVICE, TRAINING, AND AFTER-SALES SUPPORT
4.7.2.6 SUPPLY CHAIN RELIABILITY
4.7.3 RECENT TRENDS IN VENDOR SELECTION
4.7.4 RISK FACTORS AND VULNERABILITIES
4.7.5 KEY PERFORMANCE INDICATORS
4.7.6 STRATEGIC RECOMMENDATIONS
4.7.7 CONCLUSION
4.8 PATENT ANALYSIS
4.8.1 PATENT QUALITY AND STRENGTH
4.8.2 PATENT FAMILIES
4.8.3 LICENSING AND COLLABORATIONS
4.8.4 REGIONAL PATENT LANDSCAPE
4.8.5 IP STRATEGY AND MANAGEMENT
4.9 SUPPLY CHAIN ANALYSIS
4.9.1 OVERVIEW
4.9.2 LOGISTIC COST SCENARIO
4.9.3 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS
4.9.4 CONCLUSION
4.1 INDUSTRY ECOSYSTEM ANALYSIS
4.10.1 INTRODUCTION
4.10.2 ECOSYSTEM ARCHITECTURE — KEY ACTORS AND ROLES
4.10.2.1 CORE TECHNOLOGY PROVIDERS
4.10.2.2 ENABLING INSTITUTIONS
4.10.3 VALUE CHAIN AND FUNCTIONAL FLOWS
4.10.3.1 RESEARCH AND DISCOVERY
4.10.3.2 CLINICAL DEVELOPMENT AND REGULATORY VALIDATION
4.10.3.3 MANUFACTURING AND QUALITY ASSURANCE
4.10.3.4 DISTRIBUTION, PROCUREMENT AND CLINICAL ADOPTION
4.10.4 MARKET ENABLERS AND INFRASTRUCTURE
4.10.4.1 SCIENTIFIC AND REGULATORY ENABLERS
4.10.4.2 REIMBURSEMENT AND HEALTH-ECONOMICS INFRASTRUCTURE
4.10.4.3 MANUFACTURING AND SUPPLY-CHAIN CAPACITY
4.10.5 INTERDEPENDENCIES AND STRATEGIC PARTNERSHIPS
4.10.5.1 ACADEMIA-INDUSTRY TECHNOLOGY TRANSFER
4.10.5.2 VERTICAL INTEGRATION AND CONTRACT MANUFACTURING
4.10.5.3 CLINICAL NETWORKS AND KOL ECOSYSTEMS
4.10.6 RISKS, CONSTRAINTS AND SYSTEMIC VULNERABILITIES
4.10.6.1 REGULATORY COMPLEXITY FOR COMBINED PRODUCTS
4.10.6.2 SUPPLY-CHAIN CONCENTRATION AND MATERIAL RISK
4.10.6.3 EVIDENCE AND REIMBURSEMENT UNCERTAINTY
4.10.6.4 CLINICAL OPERATIONAL BARRIERS
4.10.7 STRATEGIC IMPLICATIONS AND RECOMMENDATIONS
4.10.8 OUTLOOK — EVOLUTION OF THE ECOSYSTEM
4.10.9 CONCLUSION
4.11 INNOVATION TRACKER AND STRATEGIC ANALYSIS
4.11.1 INTRODUCTION
4.11.2 RECENT TECHNOLOGICAL INNOVATIONS
4.11.2.1 ADVANCED PHOTOSENSITIZERS
4.11.2.2 OXYGEN-SELF-SUFFICIENT PLATFORMS
4.11.2.3 ALTERNATIVE ACTIVATION MODALITIES
4.11.2.4 SMART NANOPLATFORMS
4.11.2.5 NOVEL CHEMICAL STRUCTURES
4.11.3 STRATEGIC INNOVATIONS IN DELIVERY SYSTEMS
4.11.3.1 LIGHT DELIVERY DEVICES
4.11.3.2 COMBINATION THERAPIES
4.11.3.3 IMAGING INTEGRATION
4.11.4 KEY CHALLENGES
4.11.5 STRATEGIC THEMES
4.11.6 STRATEGIC IMPLICATIONS FOR MARKET PLAYERS
4.11.7 RECOMMENDATIONS
4.11.8 OUTLOOK AND STRATEGIC RISKS
4.11.9 CONCLUSION
4.12 PRICING ANALYSIS
4.12.1 INTRODUCTION
4.12.2 COMPONENTS OF THE TOTAL TREATMENT PRICE
4.12.2.1 PHOTOSENSITIZING AGENT (DRUG) COSTS
4.12.2.2 DEVICE CAPITAL AND MAINTENANCE COST
4.12.2.3 CONSUMABLES AND PROCEDURAL OVERHEAD
4.12.2.4 INDIRECT AND DOWNSTREAM COSTS
4.12.3 PRICING MODELS AND APPROACHES
4.12.3.1 COST-PLUS AND MARKUP MODELS
4.12.3.2 VALUE-BASED AND OUTCOMES-LINKED PRICING
4.12.3.3 BUNDLED PAYMENTS AND PROCEDURAL TARIFFS
4.12.3.4 SUBSCRIPTION AND MANAGED-SERVICE MODELS FOR DEVICES
4.12.4 REIMBURSEMENT LANDSCAPE
4.12.4.1 UNITED STATES: MEDICARE AND COMMERCIAL PAYERS
4.12.4.2 EUROPE AND OTHER HIGH-INCOME MARKETS
4.12.4.3 EMERGING MARKETS AND OUT-OF-POCKET DYNAMICS
4.12.5 REGIONAL PRICE DIFFERENTIALS AND DRIVERS
4.12.5.1 MANUFACTURING FOOTPRINT AND SUPPLY-CHAIN EFFECTS
4.12.5.2 REGULATORY BURDEN AND MARKET ACCESS TIMELINES
4.12.5.3 CLINICAL PRACTICE PATTERNS AND REIMBURSEMENT POLICY
4.12.6 PRICE SENSITIVITY, ACCESS, AND EQUITY
4.12.6.1 PRICE ELASTICITY IN HOSPITAL PROCUREMENT
4.12.6.2 PATIENT ACCESS AND SOCIOECONOMIC BARRIERS
4.12.7 COMPETITIVE & STRATEGIC PRICING IMPLICATIONS
4.12.7.1 DIFFERENTIATION-BASED PREMIUM PRICING
4.12.7.2 PENETRATION PRICING AND VOLUME STRATEGIES
4.12.7.3 MANAGED ENTRY AGREEMENTS AND OUTCOMES GUARANTEES
4.12.8 RECOMMENDATIONS FOR STAKEHOLDERS
4.12.8.1 FOR MANUFACTURERS
4.12.8.2 FOR PROVIDERS AND HOSPITAL SYSTEMS
4.12.8.3 FOR PAYERS AND POLICYMAKERS
4.12.9 RISKS, UNCERTAINTIES, AND FUTURE PRICE PRESSURES
4.12.10 CONCLUSION
5 TARIFFS & IMPACT ON THE MARKET
5.1 INTRODUCTION
5.2 TARIFF LANDSCAPE RELEVANT TO PDT PRODUCTS
5.2.1 CATEGORIES OF TRADE EXPOSURE
5.2.2 RECENT AND EMERGING TARIFF MEASURES OF CONSEQUENCE
5.3 DIRECT COST IMPACTS
5.3.1 INCREASED LANDED COSTS AND MARGIN COMPRESSION
5.3.2 PRICE VOLATILITY AND PROCUREMENT BUDGETING
5.4 SUPPLY-CHAIN & MANUFACTURING IMPLICATIONS
5.4.1 SUPPLIER DIVERSIFICATION AND RESHORING INCENTIVES
5.4.2 SOURCING OF HIGH-VALUE NANOMATERIALS AND COMPONENTS
5.4.3 REGULATORY AND QUALIFICATION COSTS FOR NEW SUPPLIERS
5.5 CLINICAL ACCESS, PRICING & REIMBURSEMENT EFFECTS
5.5.1 ACCESS RISK FOR PATIENTS AND PROVIDERS
5.5.2 REIMBURSEMENT PRESSURE AND HEALTH-ECONOMIC ASSESSMENTS
5.6 R&D, INNOVATION & COMPETITIVE IMPLICATIONS
5.6.1 DISRUPTION OF RESEARCH SUPPLIES AND COLLABORATION FLOWS
5.6.2 STRATEGIC REPOSITIONING AND COMPETITIVE ADVANTAGE
5.7 POLICY, COMPLIANCE & REGULATORY CONSIDERATIONS
5.7.1 USE OF WTO AND PREFERENTIAL TRADE RULES
5.7.2 TARIFF MITIGATION TOOLS AND ADVOCACY
5.8 RECOMMENDATIONS FOR STAKEHOLDERS
5.9 CONCLUSION
6 REGULATION COVERAGE
6.1 PRODUCT CODES
6.1.1 CERTIFIED STANDARDS
6.1.2 SAFETY STANDARDS
6.1.3 MATERIAL HANDLING & STORAGE
6.1.4 TRANSPORT & PRECAUTIONS
6.1.5 HAZARD IDENTIFICATION
6.1.6 CONCLUSION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF CANCER
7.1.2 GROWING PREFERENCE FOR MINIMALLY INVASIVE THERAPIES
7.1.3 TECHNOLOGICAL ADVANCEMENTS IN PHOTOSENSITIZERS AND DEVICES
7.1.4 EXPANDING RESEARCH AND CLINICAL DEVELOPMENT PIPELINE
7.2 RESTRAINTS
7.2.1 LIMITED DEPTH OF LIGHT PENETRATION
7.2.2 HIGH COST OF TREATMENT
7.3 OPPORTUNITIES
7.3.1 INTEGRATION WITH OTHER CANCER THERAPIES
7.3.2 DEVELOPMENT OF NOVEL PHOTOSENSITIZERS
7.3.3 M&A AND PARTNERSHIPS WITH ONCOLOGY DEVICE/LASER FIRMS AND PHARMA
7.4 CHALLENGES
7.4.1 TUMOR HYPOXIA AS A BIOLOGICAL BARRIER TO PHOTODYNAMIC THERAPY EFFICACY
7.4.2 COMPETITION FROM ALTERNATIVE TREATMENTS
8 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 PHOTOSENSITIZER DRUGS
8.3 PHOTODYNAMIC THERAPY DEVICES
9 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION
9.1 OVERVIEW
9.2 SKIN & CUTANEOUS ONCOLOGY
9.3 HEAD & NECK
9.4 ESOPHAGAL
9.5 LUNG
9.6 BLADDER
9.7 CERVICAL
9.8 PROSTATE
10 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY
10.1 OVERVIEW
10.2 STANDALONE THERAPY
10.3 ADJUNCTIVE THERAPY
10.4 PALLIATION THERAPY
10.5 OTHERS
11 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE
11.1 OVERVIEW
11.2 EXTERNAL BEAM
11.3 INTRACAVITARY (ENDOSCOPIC) DELIVERY
11.4 INTERSTITIAL (INTERNAL) DELIVERY
11.5 OTHERS
12 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE
12.1 OVERVIEW
12.2 EARLY-STAGE CANCER
12.3 LATE-STAGE CANCER
13 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS
13.1 OVERVIEW
13.2 GERIATRIC
13.3 ADULTS
13.4 PEDIATRIC
14 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER
14.1 OVERVIEW
14.2 HOSPITALS
14.3 DERMATOLOGY & SKIN-CANCER CLINICS
14.4 AMBULATORY SURGICAL CENTERS (ASCS)
14.5 ACADEMIC & RESEARCH INSTITUTES
14.6 OTHERS
15 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDER
15.3 THIRD PARTY DISTRIBUTORS
15.4 ONLINE
15.5 OTHERS
16 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION
16.1 EUROPE
16.1.1 GERMANY
16.1.2 U.K.
16.1.3 FRANCE
16.1.4 ITALY
16.1.5 SPAIN
16.1.6 RUSSIA
16.1.7 TURKEY
16.1.8 SWITZERLAND
16.1.9 BELGIUM
16.1.10 NETHERLANDS
16.1.11 SWEDEN
16.1.12 DENMARK
16.1.13 NORWAY
16.1.14 FINLAND
16.1.15 REST OF EUROPE
17 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: GLOBAL
18 SWOT ANALYSIS
19 COMPANY PROFILE
19.1 NOVERTIS AG
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENT
19.2 GALDERMA S. A.
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENTS
19.3 PHOTOCURE
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENT
19.4 ADVANZ PHARMA CORP.
19.4.1 COMPANY SNAPSHOT
19.4.2 COMPANY SHARE ANALYSIS
19.4.3 PRODUCT PORTFOLIO
19.4.4 RECENT DEVELOPMENT
19.5 AMERISOURCE BERGEN CORPORATION
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 COMPANY SHARE ANALYSIS
19.5.4 PRODUCT PORTFOLIO
19.5.5 RECENT DEVELOPMENT
19.6 BIOFRONTERA AG
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT DEVELOPMENTS
19.7 BIOLITEC HOLDING GMBH & CO KG
19.7.1 COMPANY SNAPSHOT
19.7.2 PRODUCT PORTFOLIO
19.7.3 RECENT DEVELOPMENT
19.8 CARDINAL HEALTH
19.8.1 COMPANY SNAPSHOT
19.8.2 REVENUE ANALYSIS
19.8.3 PRODUCT PORTFOLIO
19.8.4 RECENT DEVELOPMENT
19.9 HEMERION THERAPEUTICS
19.9.1 COMPANY SNAPSHOT
19.9.2 PRODUCT PORTFOLIO
19.9.3 RECENT DEVELOPMENTS
19.1 IMPACT BIOTECH
19.10.1 COMPANY SNAPSHOT
19.10.2 PRODUCT PORTFOLIO
19.10.3 RECENT DEVELOPMENTS
19.11 INOVA
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT DEVELOPMENT
19.12 LUMIBIRD
19.12.1 COMPANY SNAPSHOT
19.12.2 REVENUE ANALYSIS
19.12.3 PRODUCT PORTFOLIO
19.12.4 RECENT DEVELOPMENT
19.13 LUZITIN
19.13.1 COMPANY SNAPSHOT
19.13.2 PRODUCT PORTFOLIO
19.13.3 RECENT DEVELOPMENT
19.14 MCKESSON
19.14.1 COMPANY SNAPSHOT
19.14.2 REVENUE ANALYSIS
19.14.3 PRODUCT PORTFOLIO
19.14.4 RECENT DEVELOPMENTS
19.15 MODULIGHT CORPORATION
19.15.1 COMPANY SNAPSHOT
19.15.2 REVENUE ANALYSIS
19.15.3 PRODUCT PORTFOLIO
19.15.4 RECENT DEVELOPMENT
19.16 ONCOLUX INC (FORMERLY LUMEDA INC.)
19.16.1 COMPANY SNAPSHOT
19.16.2 PRODUCT PORTFOLIO
19.16.3 RECENT DEVELOPMENT
19.17 SUN PHARMACEUTICAL INDUSTRIES LTD
19.17.1 COMPANY SNAPSHOT
19.17.2 REVENUE ANALYSIS
19.17.3 PRODUCT PORTFOLIO
19.17.4 RECENT DEVELOPMENT
19.18 THERALASE TECHNOLOGIES INC.
19.18.1 COMPANY SNAPSHOT
19.18.2 REVENUE ANALYSIS
19.18.3 PRODUCT PORTFOLIO
19.18.4 RECENT DEVELOPMENT
20 QUESTIONNAIRE
21 RELATED REPORTS
표 목록
TABLE 1 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 2 EUROPE PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2019-2028 (USD THOUSAND)
TABLE 3 EUROPE PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 4 EUROPE PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 5 EUROPE PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 6 EUROPE PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 7 EUROPE LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 8 EUROPE ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 9 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 10 EUROPE SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 11 EUROPE SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 12 EUROPE SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 13 EUROPE HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 14 EUROPE HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 15 EUROPE HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 16 EUROPE ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 17 EUROPE ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 18 EUROPE ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 19 EUROPE LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 20 EUROPE LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 21 EUROPE LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 22 EUROPE BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 23 EUROPE BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 24 EUROPE BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 25 EUROPE CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 26 EUROPE CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 27 EUROPE CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 28 EUROPE PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 29 EUROPE PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 30 EUROPE PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 31 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 32 EUROPE STANDALONE THERAPY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 33 EUROPE ADJUNCTIVE THERAPY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 34 EUROPE PALLIATION THERAPY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 35 EUROPE OTHERS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 36 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 37 EUROPE EXTERNAL BEAM IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 38 EUROPE INTRACAVITARY (ENDOSCOPIC) DELIVERY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 39 EUROPE INTERSTITIAL (INTERNAL) DELIVERY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 40 EUROPE OTHERS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 41 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 42 EUROPE EARLY-STAGE CANCER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 43 EUROPE LATE-STAGE CANCER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 44 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 45 EUROPE GERIATRIC IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 46 EUROPE ADULTS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 47 EUROPE PEDIATRIC IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 48 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 49 EUROPE HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 50 EUROPE HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 51 EUROPE HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 52 EUROPE DERMATOLOGY & SKIN-CANCER CLINICS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 53 EUROPE AMBULATORY SURGICAL CENTERS (ASCS) IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 54 EUROPE ACADEMIC & RESEARCH INSTITUTES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 55 EUROPE OTHERS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 56 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 57 EUROPE DIRECT TENDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 58 EUROPE THIRD PARTY DISTRIBUTORS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 59 EUROPE ONLINE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 60 EUROPE OTHERS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY REGION, 2018-2032 (USD THOUSAND)
TABLE 61 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY COUNTRY, 2018-2032 (USD THOUSAND)
TABLE 62 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 63 EUROPE PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 64 EUROPE PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 65 EUROPE PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 66 EUROPE LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 67 EUROPE ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 68 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 69 EUROPE SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 70 EUROPE SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 71 EUROPE HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 72 EUROPE HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 73 EUROPE ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 74 EUROPE ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 75 EUROPE LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 76 EUROPE LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 77 EUROPE BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 78 EUROPE BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 79 EUROPE CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 80 EUROPE CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 81 EUROPE PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 82 EUROPE PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 83 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 84 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 85 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 86 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 87 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 88 EUROPE HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 89 EUROPE HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 90 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 91 GERMANY CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 92 GERMANY PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 93 GERMANY PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 94 GERMANY PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 95 GERMANY LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 96 GERMANY ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 97 GERMANY CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 98 GERMANY SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 99 GERMANY SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 100 GERMANY HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 101 GERMANY HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 102 GERMANY ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 103 GERMANY ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 104 GERMANY LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 105 GERMANY LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 106 GERMANY BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 107 GERMANY BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 108 GERMANY CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 109 GERMANY CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 110 GERMANY PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 111 GERMANY PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 112 GERMANY CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 113 GERMANY CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 114 GERMANY CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 115 GERMANY CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 116 GERMANY CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 117 GERMANY HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 118 GERMANY HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 119 GERMANY CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 120 U.K. CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 121 U.K. PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 122 U.K. PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 123 U.K. PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 124 U.K. LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 125 U.K. ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 126 U.K. CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 127 U.K. SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 128 U.K. SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 129 U.K. HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 130 U.K. HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 131 U.K. ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 132 U.K. ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 133 U.K. LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 134 U.K. LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 135 U.K. BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 136 U.K. BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 137 U.K. CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 138 U.K. CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 139 U.K. PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 140 U.K. PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 141 U.K. CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 142 U.K. CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 143 U.K. CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 144 U.K. CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 145 U.K. CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 146 U.K. HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 147 U.K. HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 148 U.K. CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 149 FRANCE CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 150 FRANCE PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 151 FRANCE PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 152 FRANCE PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 153 FRANCE LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 154 FRANCE ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 155 FRANCE CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 156 FRANCE SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 157 FRANCE SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 158 FRANCE HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 159 FRANCE HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 160 FRANCE ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 161 FRANCE ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 162 FRANCE LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 163 FRANCE LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 164 FRANCE BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 165 FRANCE BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 166 FRANCE CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 167 FRANCE CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 168 FRANCE PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 169 FRANCE PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 170 FRANCE CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 171 FRANCE CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 172 FRANCE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 173 FRANCE CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 174 FRANCE CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 175 FRANCE HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 176 FRANCE HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 177 FRANCE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 178 ITALY CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 179 ITALY PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 180 ITALY PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 181 ITALY PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 182 ITALY LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 183 ITALY ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 184 ITALY CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 185 ITALY SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 186 ITALY SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 187 ITALY HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 188 ITALY HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 189 ITALY ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 190 ITALY ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 191 ITALY LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 192 ITALY LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 193 ITALY BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 194 ITALY BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 195 ITALY CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 196 ITALY CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 197 ITALY PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 198 ITALY PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 199 ITALY CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 200 ITALY CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 201 ITALY CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 202 ITALY CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 203 ITALY CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 204 ITALY HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 205 ITALY HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 206 ITALY CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 207 SPAIN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 208 SPAIN PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 209 SPAIN PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 210 SPAIN PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 211 SPAIN LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 212 SPAIN ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 213 SPAIN CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 214 SPAIN SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 215 SPAIN SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 216 SPAIN HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 217 SPAIN HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 218 SPAIN ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 219 SPAIN ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 220 SPAIN LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 221 SPAIN LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 222 SPAIN BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 223 SPAIN BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 224 SPAIN CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 225 SPAIN CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 226 SPAIN PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 227 SPAIN PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 228 SPAIN CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 229 SPAIN CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 230 SPAIN CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 231 SPAIN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 232 SPAIN CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 233 SPAIN HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 234 SPAIN HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 235 SPAIN CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 236 RUSSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 237 RUSSIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 238 RUSSIA PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 239 RUSSIA PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 240 RUSSIA LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 241 RUSSIA ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 242 RUSSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 243 RUSSIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 244 RUSSIA SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 245 RUSSIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 246 RUSSIA HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 247 RUSSIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 248 RUSSIA ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 249 RUSSIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 250 RUSSIA LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 251 RUSSIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 252 RUSSIA BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 253 RUSSIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 254 RUSSIA CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 255 RUSSIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 256 RUSSIA PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 257 RUSSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 258 RUSSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 259 RUSSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 260 RUSSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 261 RUSSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 262 RUSSIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 263 RUSSIA HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 264 RUSSIA CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 265 TURKEY CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 266 TURKEY PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 267 TURKEY PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 268 TURKEY PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 269 TURKEY LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 270 TURKEY ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 271 TURKEY CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 272 TURKEY SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 273 TURKEY SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 274 TURKEY HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 275 TURKEY HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 276 TURKEY ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 277 TURKEY ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 278 TURKEY LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 279 TURKEY LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 280 TURKEY BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 281 TURKEY BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 282 TURKEY CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 283 TURKEY CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 284 TURKEY PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 285 TURKEY PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 286 TURKEY CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 287 TURKEY CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 288 TURKEY CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 289 TURKEY CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 290 TURKEY CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 291 TURKEY HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 292 TURKEY HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 293 TURKEY CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 294 SWITZERLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 295 SWITZERLAND PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 296 SWITZERLAND PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 297 SWITZERLAND PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 298 SWITZERLAND LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 299 SWITZERLAND ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 300 SWITZERLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 301 SWITZERLAND SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 302 SWITZERLAND SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 303 SWITZERLAND HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 304 SWITZERLAND HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 305 SWITZERLAND ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 306 SWITZERLAND ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 307 SWITZERLAND LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 308 SWITZERLAND LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 309 SWITZERLAND BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 310 SWITZERLAND BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 311 SWITZERLAND CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 312 SWITZERLAND CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 313 SWITZERLAND PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 314 SWITZERLAND PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 315 SWITZERLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 316 SWITZERLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 317 SWITZERLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 318 SWITZERLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 319 SWITZERLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 320 SWITZERLAND HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 321 SWITZERLAND HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 322 SWITZERLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 323 BELGIUM CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 324 BELGIUM PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 325 BELGIUM PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 326 BELGIUM PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 327 BELGIUM LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 328 BELGIUM ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 329 BELGIUM CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 330 BELGIUM SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 331 BELGIUM SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 332 BELGIUM HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 333 BELGIUM HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 334 BELGIUM ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 335 BELGIUM ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 336 BELGIUM LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 337 BELGIUM LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 338 BELGIUM BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 339 BELGIUM BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 340 BELGIUM CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 341 BELGIUM CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 342 BELGIUM PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 343 BELGIUM PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 344 BELGIUM CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 345 BELGIUM CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 346 BELGIUM CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 347 BELGIUM CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 348 BELGIUM CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 349 BELGIUM HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 350 BELGIUM HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 351 BELGIUM CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 352 NETHERLANDS CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 353 NETHERLANDS PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 354 NETHERLANDS PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 355 NETHERLANDS PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 356 NETHERLANDS LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 357 NETHERLANDS ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 358 NETHERLANDS CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 359 NETHERLANDS SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 360 NETHERLANDS SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 361 NETHERLANDS HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 362 NETHERLANDS HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 363 NETHERLANDS ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 364 NETHERLANDS ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 365 NETHERLANDS LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 366 NETHERLANDS LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 367 NETHERLANDS BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 368 NETHERLANDS BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 369 NETHERLANDS CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 370 NETHERLANDS CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 371 NETHERLANDS PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 372 NETHERLANDS PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 373 NETHERLANDS CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 374 NETHERLANDS CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 375 NETHERLANDS CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 376 NETHERLANDS CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 377 NETHERLANDS CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 378 NETHERLANDS HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 379 NETHERLANDS HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 380 NETHERLANDS CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 381 SWEDEN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 382 SWEDEN PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 383 SWEDEN PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 384 SWEDEN PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 385 SWEDEN LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 386 SWEDEN ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 387 SWEDEN CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 388 SWEDEN SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 389 SWEDEN SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 390 SWEDEN HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 391 SWEDEN HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 392 SWEDEN ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 393 SWEDEN ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 394 SWEDEN LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 395 SWEDEN LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 396 SWEDEN BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 397 SWEDEN BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 398 SWEDEN CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 399 SWEDEN CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 400 SWEDEN PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 401 SWEDEN PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 402 SWEDEN CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 403 SWEDEN CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 404 SWEDEN CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 405 SWEDEN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 406 SWEDEN CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 407 SWEDEN HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 408 SWEDEN HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 409 SWEDEN CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 410 DENMARK CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 411 DENMARK PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 412 DENMARK PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 413 DENMARK PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 414 DENMARK LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 415 DENMARK ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 416 DENMARK CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 417 DENMARK SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 418 DENMARK SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 419 DENMARK HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 420 DENMARK HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 421 DENMARK ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 422 DENMARK ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 423 DENMARK LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 424 DENMARK LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 425 DENMARK BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 426 DENMARK BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 427 DENMARK CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 428 DENMARK CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 429 DENMARK PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 430 DENMARK PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 431 DENMARK CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 432 DENMARK CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 433 DENMARK CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 434 DENMARK CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 435 DENMARK CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 436 DENMARK HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 437 DENMARK HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 438 DENMARK CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 439 NORWAY CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 440 NORWAY PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 441 NORWAY PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 442 NORWAY PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 443 NORWAY LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 444 NORWAY ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 445 NORWAY CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 446 NORWAY SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 447 NORWAY SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 448 NORWAY HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 449 NORWAY HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 450 NORWAY ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 451 NORWAY ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 452 NORWAY LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 453 NORWAY LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 454 NORWAY BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 455 NORWAY BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 456 NORWAY CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 457 NORWAY CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 458 NORWAY PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 459 NORWAY PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 460 NORWAY CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 461 NORWAY CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 462 NORWAY CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 463 NORWAY CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 464 NORWAY CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 465 NORWAY HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 466 NORWAY HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 467 NORWAY CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 468 FINLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 469 FINLAND PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY CLASS, 2018-2032 (USD THOUSAND)
TABLE 470 FINLAND PHOTOSENSITIZER DRUGS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY FORMULATION, 2018-2032 (USD THOUSAND)
TABLE 471 FINLAND PHOTODYNAMIC THERAPY DEVICES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 472 FINLAND LIGHT DELIVERY SYSTEMS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 473 FINLAND ACCESSORIES & CONSUMABLES IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 474 FINLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032 (USD THOUSAND)
TABLE 475 FINLAND SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 476 FINLAND SKIN & CUTANEOUS ONCOLOGY IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 477 FINLAND HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 478 FINLAND HEAD & NECK IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 479 FINLAND ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 480 FINLAND ESOPHAGAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 481 FINLAND LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 482 FINLAND LUNG IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 483 FINLAND BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 484 FINLAND BLADDER IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 485 FINLAND CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 486 FINLAND CERVICAL IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 487 FINLAND PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
TABLE 488 FINLAND PROSTATE IN CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 489 FINLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032 (USD THOUSAND)
TABLE 490 FINLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032 (USD THOUSAND)
TABLE 491 FINLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032 (USD THOUSAND)
TABLE 492 FINLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032 (USD THOUSAND)
TABLE 493 FINLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032 (USD THOUSAND)
TABLE 494 FINLAND HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY TYPE, 2018-2032 (USD THOUSAND)
TABLE 495 FINLAND HOSPITALS IN CANCER PHOTODYNAMIC THERAPY MARKET, BY SIZE, 2018-2032 (USD THOUSAND)
TABLE 496 FINLAND CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD THOUSAND)
TABLE 497 REST OF EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032 (USD THOUSAND)
그림 목록
FIGURE 1 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET: SEGMENTATION
FIGURE 2 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET: DROC ANALYSIS
FIGURE 4 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET: EUROPE VS REGIONAL ANALYSIS
FIGURE 5 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET: SEGMENTATION
FIGURE 10 EXECUTIVE SUMMARY
FIGURE 11 STRATEGIC DECISIONS
FIGURE 12 TWO SEGMENTS COMPRISE THE EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE (2024)
FIGURE 13 INCREASING PREVALENCE OF CANCER ACROSS GLOBE EXPECTED TO DRIVE THE EUROPE CANCER PHOTODYNAMIC THERAPY MARKET IN THE FORECAST PERIOD OF 2025 TO 2032
FIGURE 14 PHOTOSENSITIZER DRUGS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CANCER PHOTODYNAMIC THERAPY MARKET IN 2025 & 2032
FIGURE 15 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET-MARKET OVERVIEW
FIGURE 16 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2024
FIGURE 17 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2024
FIGURE 18 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032
FIGURE 19 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PRODUCT TYPE, 2018-2032
FIGURE 20 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2024
FIGURE 21 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2024
FIGURE 22 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032
FIGURE 23 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY CANCER INDICATION, 2018-2032
FIGURE 24 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2024
FIGURE 25 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2024
FIGURE 26 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032
FIGURE 27 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY THERAPY MODALITY, 2018-2032
FIGURE 28 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2024
FIGURE 29 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2024
FIGURE 30 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032
FIGURE 31 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PROCEDURE TECHNIQUE, 2018-2032
FIGURE 32 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2024
FIGURE 33 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2024
FIGURE 34 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032
FIGURE 35 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISEASE STAGE, 2018-2032
FIGURE 36 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2024
FIGURE 37 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032
FIGURE 38 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032
FIGURE 39 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY PATIENT DEMOGRAPHICS, 2018-2032
FIGURE 40 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2024
FIGURE 41 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2024
FIGURE 42 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032
FIGURE 43 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY END USER, 2018-2032
FIGURE 44 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024
FIGURE 45 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2024
FIGURE 46 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032
FIGURE 47 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032
FIGURE 48 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET: SNAPSHOT (2024)
FIGURE 49 EUROPE CANCER PHOTODYNAMIC THERAPY MARKET: COMPANY SHARE 2024 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
